Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-044982)

Filing Details

Accession Number:: 0001181431-11-044982
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-11 12:51:03
Reporting Period:: 2011-08-10

Filing Date:: 2011-08-11
Accepted Time:: 2011-08-11 12:51:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Transcept Pharmaceuticals Inc	TSPT	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1210529	A Glenn Oclassen	C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-10	27,833	$2.82	298,633	No	4	P	Direct
Common Stock	Acquisiton	2011-08-11	2,167	$2.82	300,800	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,457	Indirect	See footnote

Footnotes

The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $2.72 to $2.86 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
Shares held directly by the Reporting Person's spouse.